MiR-150 Expression in Chronic Myeloid Leukemia: Relation to Imatinib Response
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-150 Expression in Chronic Myeloid Leukemia: Relation to Imatinib Response
Authors
Keywords
-
Journal
Labmedicine
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-04-09
DOI
10.1093/labmed/lmab040
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer
- (2020) Muhammad Tarek Abdel Ghafar et al. MOLECULAR BIOLOGY REPORTS
- Chronic myeloid leukemia: the concepts of resistance and persistence and the relationship with the BCR-ABL1 transcript type
- (2019) Michele Baccarani et al. LEUKEMIA
- Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic Approaches
- (2019) Barbara Izzo et al. Frontiers in Oncology
- The impact of early molecular response in children and adolescents with chronic myeloid leukemia treated with imatinib: a single-center study from China
- (2018) Haigang Shao et al. LEUKEMIA & LYMPHOMA
- Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance
- (2018) Jingru Zhang et al. Blood Cancer Journal
- BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia
- (2018) Klara Srutova et al. HAEMATOLOGICA
- Chronic myeloid leukemia: Existing therapeutic options and strategies to overcome drug resistance
- (2018) Vivek Kumar Singh et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- The predictive value of early molecular response in chronic myeloid leukaemia patients treated with imatinib in a single real-world medical centre in a developing country
- (2017) PC Bee et al. SINGAPORE MEDICAL JOURNAL
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- Clinical significance of microRNAs in chronic and acute human leukemia
- (2016) Chien-Hung Yeh et al. Molecular Cancer
- miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathways
- (2016) Zhi Hong Fang et al. Cell Death & Disease
- MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia
- (2016) Chiranjib Chakraborty et al. Oncotarget
- The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries
- (2015) V S Hoffmann et al. LEUKEMIA
- c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase–Activated Leukemias
- (2015) Nidal Muvarak et al. MOLECULAR CANCER RESEARCH
- Studies on microRNAs that are correlated with the cancer stem cells in chronic myeloid leukemia
- (2014) Xishan Zhu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The role of miR-150 in normal and malignant hematopoiesis
- (2013) Y He et al. ONCOGENE
- MicroRNA-150 Expression Induces Myeloid Differentiation of Human Acute Leukemia Cells and Normal Hematopoietic Progenitors
- (2013) Valerie A. Morris et al. PLoS One
- Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
- (2012) B Hanfstein et al. LEUKEMIA
- Assessment of BCR-ABL1 Transcript Levels at 3 Months Is the Only Requirement for Predicting Outcome for Patients With Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors
- (2011) David Marin et al. JOURNAL OF CLINICAL ONCOLOGY
- Expression patterns of microRNAs associated with CML phases and their disease related targets
- (2011) Kateřina Machová Poláková et al. Molecular Cancer
- Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia
- (2010) S. Flamant et al. HAEMATOLOGICA
- C/EBPε directs granulocytic-vs-monocytic lineage determination and confers chemotactic function via Hlx
- (2009) Stephanie Halene et al. EXPERIMENTAL HEMATOLOGY
- Requirement of c-Myb for p210BCR/ABL-dependent transformation of hematopoietic progenitors and leukemogenesis
- (2008) M. R. Lidonnici et al. BLOOD
- Analyzing real-time PCR data by the comparative CT method
- (2008) Thomas D Schmittgen et al. Nature Protocols
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started